Associations of polymorphic variant of MnSOD gene with breast cancer in residents of the Altai Region

Bulletin of Experimental Biology and Medicine

Volumn 147, Issue 1, 2009, Pages 84-87

  Kostrykina, N A ^a   Pechkovskiy, E A ^a   Boyarskikh, U A ^a   Sushko, A G ^a   Voronina, E N ^a   Lazarev, A F ^b   Petrova, V D ^b   Zarubina, N A ^b   Selezneva, I A ^b   Sinkina, T V ^b   Terekhova, S A ^b   Filipenko, M L ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Breast cancer; MnSOD; Polymerase chain reaction; SOD2

Indexed keywords

ALANINE; MITOCHONDRIAL ENZYME; MITOCHONDRIAL SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VALINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; RESIDENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SIBERIA; SUPEROXIDE DISMUTASE;

NICOTIANA TABACUM;

EID: 67649414193     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-009-0442-1     Document Type: Article

References (15)

1. Statistics of Malignant Tumors in Russia and CIS Countries in 2004, Vestn. Rossiisk. Onkol. Nats. Tsentra, 17, No. 3, Suppl. 1, 78-101 (2006).
2. C. B. Ambrosone, J. L. Freudenheim, P. A. Thompson, et al., Cancer Res., 59, No. 3, 602-606 (1999).
3. Q. Cai, X. O. Shu, W. Wen, et al., Breast Cancer Res., 6, No. 6, R647-R655 (2004).
4. A. Cebrian, P. D. Pharoah, S. Ahmed, et al., Cancer Res., 6, No. 6, 1225-1234 (2006).
5. Commonly Studied Single-Nucleotide Polymorphisms and Breast Cancer: Results from the Breast Cancer Association Consortium, J. Natl. Cancer Inst., 98, No. 19, 1382-1396 (2006).
6. D. G. Cox, R. M. Tamimi, and D. J. Hunter, BMC Cancer, 6, 217 (2006).
7. K. M. Egan, P. A. Thompson, L. Titus-Ernstoff, et al., Cancer Lett., 199, No. 1, 27-33 (2003).
8. M. M. Gaudet, M. D. Gammon, R. M. Santella, et al., Cancer Causes Control, 16, No. 10, 1225-1234 (2005).
9. S. E. Johnatty, C. M. Nagle, A. B. Spurdle, et al., Gynecol. Oncol., 107, No. 3, 388-391 (2007).
10. D. Kang, K. M. Lee, S. K. Park, et al., Cancer Epidemiol. Biomarkers Prev., 16, No. 8, 1581-1586 (2007).
11. J. A. Knight, U. V. Onay, S. Wells, et al., Ibid., 13, No. 1, 146-149 (2004).
12. R. C. Millikan, J. Player, A. R. de Cotret, et al. Breast Cancer Res., 6, No. 4, R264-R274 (2004).
13. K. Mitrunen, P. Sillanpaa, V. Kataja, et al., Carcinogenesis, 22, No. 5, 827-829 (2001).
14. T. E. Slanger, J. Chang-Claude, and S. Wang-Gohrke, Cancer Causes Control, 17, No. 8, 1025-1031 (2006).
15. R. M. Tamimi, S. E. Hankinson, D. Spiegelman, et al., Cancer Epidemiol. Biomarkers Prev., 13, No. 6, 989-996 (2004).